Health Technology Assessment

Health Technology Assessment (HTA) is a multidisciplinary process that evaluates the social, economic, organizational, and ethical implications of a health technology at different points in its lifecycle. The main objective of HTA is to pro…

Health Technology Assessment

Health Technology Assessment (HTA) is a multidisciplinary process that evaluates the social, economic, organizational, and ethical implications of a health technology at different points in its lifecycle. The main objective of HTA is to provide decision-makers with evidence-based information to inform resource allocation decisions and improve health outcomes. In this explanation, we will discuss key terms and vocabulary related to HTA in the context of the Global Certificate in Health Economics and Outcomes Research.

1. Health Technology: Health technology refers to any device, medicine, vaccine, procedure, or system used in the prevention, diagnosis, or treatment of medical conditions. Examples of health technologies include MRI machines, HIV medications, and telemedicine platforms. 2. Lifecycle: The lifecycle of a health technology refers to the various stages it goes through from development to disposal. HTA can be conducted at different stages of the lifecycle, including pre-market (before it is available for use), during market (while it is being used), and post-market (after it has been in use for some time). 3. Multidisciplinary: HTA is a multidisciplinary process, meaning it involves professionals from different fields, such as medicine, economics, engineering, and social sciences. This allows for a comprehensive evaluation of health technologies, taking into account various perspectives and areas of expertise. 4. Social, Economic, Organizational, and Ethical Implications: HTA evaluates the impact of health technologies on society, the economy, organizations, and ethics. This includes assessing the costs and benefits of the technology, its impact on healthcare systems and organizations, and any ethical considerations related to its use. 5. Resource Allocation Decisions: HTA provides evidence-based information to inform resource allocation decisions, which refers to how healthcare resources (e.g., budget, staff, equipment) are distributed. HTA can help decision-makers prioritize the use of resources for the most effective and efficient health technologies. 6. Improve Health Outcomes: The ultimate goal of HTA is to improve health outcomes by ensuring that health technologies are safe, effective, and cost-effective. By providing decision-makers with evidence-based information, HTA can help ensure that the right technologies are used in the right way, at the right time, and for the right patients. 7. Evidence-based Information: HTA relies on evidence-based information, which refers to information that is based on high-quality research and data. This includes clinical trials, observational studies, economic evaluations, and other forms of research that provide insight into the safety, efficacy, and cost-effectiveness of health technologies. 8. Decision-makers: Decision-makers in the context of HTA can refer to a variety of individuals and groups, including healthcare providers, hospital administrators, policymakers, and payers. HTA provides decision-makers with the evidence they need to make informed decisions about the adoption and use of health technologies. 9. Cost-effectiveness: Cost-effectiveness is a key consideration in HTA, as it refers to the relationship between the cost of a health technology and its outcomes. HTA aims to identify health technologies that provide the greatest value for money, meaning they offer the best outcomes at the lowest cost. 10. Budget Impact Analysis: Budget impact analysis is a type of economic evaluation used in HTA to estimate the financial impact of adopting a new health technology. This involves estimating the costs associated with the technology, such as the cost of the technology itself, as well as any additional costs related to its use (e.g., training, maintenance, monitoring). 11. Clinical Effectiveness: Clinical effectiveness refers to the ability of a health technology to produce the desired health outcomes in real-world settings. HTA assesses clinical effectiveness by reviewing clinical trial data, observational studies, and other forms of evidence. 12. Safety: Safety is an important consideration in HTA, as it refers to the risk of harm associated with a health technology. HTA assesses safety by reviewing clinical trial data, adverse event reports, and other forms of evidence. 13. Equity: Equity is a key consideration in HTA, as it refers to the fair distribution of healthcare resources. HTA aims to identify health technologies that promote equity, meaning they are accessible and affordable for all patients, regardless of their socioeconomic status or other factors. 14. Ethics: Ethics are an important consideration in HTA, as it involves evaluating the impact of health technologies on society. HTA assesses ethical considerations by reviewing the potential impact of the technology on issues such as autonomy, privacy, and justice. 15. Patient Engagement: Patient engagement refers to the involvement of patients and their families in the HTA process. This includes providing patients with the opportunity to provide input on the safety, efficacy, and cost-effectiveness of health technologies, as well as ensuring that the perspectives and needs of patients are taken into account in HTA recommendations. 16. Real-World Evidence: Real-world evidence refers to evidence generated from the use of health technologies in real-world settings. This includes data from observational studies, registries, and other sources that provide insight into the safety, efficacy, and cost-effectiveness of health technologies in real-world settings. 17. Systematic Review: A systematic review is a type of literature review that uses a systematic and transparent approach to identify, evaluate, and synthesize all relevant evidence on a particular topic. Systematic reviews are commonly used in HTA to assess the safety, efficacy, and cost-effectiveness of health technologies. 18. Health Technology Classification: Health technology classification refers to the categorization of health technologies based on their characteristics and intended use. HTA may use health technology classification systems to identify relevant technologies for assessment and to compare the safety, efficacy, and cost-effectiveness of similar technologies. 19. Healthcare System: A healthcare system refers to the organization and delivery of healthcare services in a particular region or country. HTA takes into account the characteristics and needs of the healthcare system when assessing the safety, efficacy, and cost-effectiveness of health technologies. 20. Horizon Scanning: Horizon scanning is a proactive approach to identifying and assessing emerging health technologies. This involves monitoring trends and developments in health technology research and development, and identifying potential opportunities and challenges related to the adoption and use of new technologies.

In summary, HTA is a multidisciplinary process that evaluates the social, economic, organizational, and ethical implications of health technologies at different points in their lifecycle. Key terms and concepts related to HTA include health technology, lifecycle, multidisciplinary, social, economic, organizational, and ethical implications, resource allocation decisions, improve health outcomes, evidence-based information, decision-makers, cost-effectiveness, budget impact analysis, clinical effectiveness, safety, equity, ethics, patient engagement, real-world evidence, systematic review, health technology classification, healthcare system, horizon scanning. Understanding these key terms and concepts is essential for those involved in HTA, as well as those seeking to develop, adopt, and use health technologies in a safe, effective, and cost-effective manner.

Key takeaways

  • Health Technology Assessment (HTA) is a multidisciplinary process that evaluates the social, economic, organizational, and ethical implications of a health technology at different points in its lifecycle.
  • HTA can be conducted at different stages of the lifecycle, including pre-market (before it is available for use), during market (while it is being used), and post-market (after it has been in use for some time).
  • Understanding these key terms and concepts is essential for those involved in HTA, as well as those seeking to develop, adopt, and use health technologies in a safe, effective, and cost-effective manner.
May 2026 intake · open enrolment
from £99 GBP
Enrol